These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 12919021)

  • 21. Resistance to anti-influenza drugs: adamantanes and neuraminidase inhibitors.
    Hurt AC; Ho HT; Barr I
    Expert Rev Anti Infect Ther; 2006 Oct; 4(5):795-805. PubMed ID: 17140356
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of the anti-influenza virus activity of cyclopentane derivatives with oseltamivir and zanamivir in vivo.
    Chand P; Bantia S; Kotian PL; El-Kattan Y; Lin TH; Babu YS
    Bioorg Med Chem; 2005 Jun; 13(12):4071-7. PubMed ID: 15911320
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Neuraminidase inhibitors against influenza].
    Med Monatsschr Pharm; 1999 Sep; 22(9):262-4. PubMed ID: 10536414
    [No Abstract]   [Full Text] [Related]  

  • 24. Peramivir for the treatment of influenza.
    Shetty AK; Peek LA
    Expert Rev Anti Infect Ther; 2012 Feb; 10(2):123-43. PubMed ID: 22339187
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of the binding affinities of peramivir and oseltamivir carboxylate to the neuraminidase enzyme.
    Bantia S; Upshaw R; Babu YS
    Antiviral Res; 2011 Sep; 91(3):288-91. PubMed ID: 21722670
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A new antiviral agent for influenza--is there a clinical niche?
    Couch RB
    N Engl J Med; 1997 Sep; 337(13):927-8. PubMed ID: 9302309
    [No Abstract]   [Full Text] [Related]  

  • 27. Synthesis of 4-azido-4-deoxy-Neu5,7,8,9Ac42en1Me. A key intermediate for the synthesis of GG167 from D-glucono-delta-lactone.
    Liu KG; Yan S; Wu YL; Yao ZJ
    Org Lett; 2004 Jun; 6(13):2269-72. PubMed ID: 15200337
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Neuraminidase inhibitor, anti-influenzal agent--mechanism of action, and how to use clinically].
    Kaji M
    Nihon Rinsho; 2003 Nov; 61(11):1975-9. PubMed ID: 14619441
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuraminidase inhibitors for influenza.
    Moscona A
    N Engl J Med; 2005 Sep; 353(13):1363-73. PubMed ID: 16192481
    [No Abstract]   [Full Text] [Related]  

  • 30. Accumulation of defective neuraminidase (NA) genes by influenza A viruses in the presence of NA inhibitors as a marker of reduced dependence on NA.
    Nedyalkova MS; Hayden FG; Webster RG; Gubareva LV
    J Infect Dis; 2002 Mar; 185(5):591-8. PubMed ID: 11865415
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Neuraminidase inhibitors oseltamivir and zanamivir: new means of defence against influenza].
    de Jong JC; Beyer WE; Rimmelzwaan GF; Fouchier RA; Osterhaus AD
    Ned Tijdschr Geneeskd; 2004 Jan; 148(2):73-9. PubMed ID: 14753128
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dihydropyrancarboxamides related to zanamivir: a new series of inhibitors of influenza virus sialidases. 1. Discovery, synthesis, biological activity, and structure-activity relationships of 4-guanidino- and 4-amino-4H-pyran-6-carboxamides.
    Smith PW; Sollis SL; Howes PD; Cherry PC; Starkey ID; Cobley KN; Weston H; Scicinski J; Merritt A; Whittington A; Wyatt P; Taylor N; Green D; Bethell R; Madar S; Fenton RJ; Morley PJ; Pateman T; Beresford A
    J Med Chem; 1998 Mar; 41(6):787-97. PubMed ID: 9526555
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Criteria for the use of anti-influenza agents].
    Kashiwagi S
    Nihon Rinsho; 2003 Nov; 61(11):1963-6. PubMed ID: 14619439
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of a human influenza type B strain with reduced sensitivity to neuraminidase inhibitor drugs.
    Hurt AC; McKimm-Breschkin JL; McDonald M; Barr IG; Komadina N; Hampson AW
    Virus Res; 2004 Jul; 103(1-2):205-11. PubMed ID: 15163511
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A practical and azide-free synthetic approach to oseltamivir from diethyl D-tartrate.
    Weng J; Li YB; Wang RB; Li FQ; Liu C; Chan AS; Lu G
    J Org Chem; 2010 May; 75(9):3125-8. PubMed ID: 20394411
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Syntheses and neuraminidase inhibitory activity of multisubstituted cyclopentane amide derivatives.
    Chand P; Babu YS; Bantia S; Rowland S; Dehghani A; Kotian PL; Hutchison TL; Ali S; Brouillette W; El-Kattan Y; Lin TH
    J Med Chem; 2004 Apr; 47(8):1919-29. PubMed ID: 15055992
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peramivir clearance in continuous renal replacement therapy.
    Thomas B; Hollister AS; Muczynski KA
    Hemodial Int; 2010 Jul; 14(3):339-40. PubMed ID: 20491974
    [No Abstract]   [Full Text] [Related]  

  • 38. Development of novel potent orally bioavailable oseltamivir derivatives active against resistant influenza A.
    Schade D; Kotthaus J; Riebling L; Kotthaus J; Müller-Fielitz H; Raasch W; Koch O; Seidel N; Schmidtke M; Clement B
    J Med Chem; 2014 Feb; 57(3):759-69. PubMed ID: 24422530
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuraminidase inhibitor resistance in influenza viruses.
    Reece PA
    J Med Virol; 2007 Oct; 79(10):1577-86. PubMed ID: 17705169
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Total synthesis of A-315675: a potent inhibitor of influenza neuraminidase.
    Hanessian S; Bayrakdarian M; Luo X
    J Am Chem Soc; 2002 May; 124(17):4716-21. PubMed ID: 11971721
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.